Back to Search Start Over

Infant Botulism, Israel, 2007–2021

Authors :
Bar Goldberg
Dana Danino
Yoel Levinsky
Itzhak Levy
Rachel Straussberg
Halima Dabaja-Younis
Alex Guri
Yotam Almagor
Diana Tasher
Daniel Elad
Zina Baider
Shlomo Blum
Oded Scheuerman
Source :
Emerging Infectious Diseases, Vol 29, Iss 2, Pp 235-241 (2023)
Publication Year :
2023
Publisher :
Centers for Disease Control and Prevention, 2023.

Abstract

Infant botulism (IB) is an intestinal toxemia that manifests as descending paralysis, constipation, and, in some cases, respiratory failure. Laboratory-confirmed IB cases are rare, and recent data in Israel are lacking. We conducted a national multicenter retrospective study of laboratory-confirmed IB cases reported in Israel during 2007–2021. A total of 8 cases were reported during the study period. During 2019–2021, incidence may have increased because of a cluster of 5 cases. Infant median age for diagnosis was 6.5 months, older than previously reported (3 months). Most cases occurred during March–July. Honey consumption was reported in 1 case, and possible environmental risk factors (living nearby rural or construction areas, dust exposure, and having a father who works as a farmer) were reported in 6 cases. Although IB is rare, its incidence in Israel may have increased over recent years, and its epidemiology and risk factors differ from cases reported previously in Israel.

Details

Language :
English
ISSN :
10806040 and 10806059
Volume :
29
Issue :
2
Database :
Directory of Open Access Journals
Journal :
Emerging Infectious Diseases
Publication Type :
Academic Journal
Accession number :
edsdoj.09bc69a5f6b4a8d9187d4c35915d8a9
Document Type :
article
Full Text :
https://doi.org/10.3201/eid2902.220991